Women's Health Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Breast Cancer
Invasive breast cancer following in situ ductal or lobular cancer studied
October 6th, 2005
The incidence of invasive breast cancer in women following in situ ductal or lobular cancer was studied in a Swiss population. Researchers from Switzerland "considered the risk of subsequent invasive breast cancer in a population-based series of 579 carcinomas in situ (CIS) of the breast (482 ductal, 88 lobular) registered between 1977 and 2002 in the Swiss Canton of Vaud." F. Levi and colleagues observed "A total of 55 cases of invasive breast cancer vs. 12.3 expected, corresponding to a standardized incidence ratio (SIR) of 4.5 (95% confidence interval [CI], 3.4-5.8)." "The SIR was 4.6 after ductal and 4.2 after lobular CIS, was similar with...
Source: Women's Health Weekly (2005-10-06)
|
